Last reviewed · How we verify

NCT04698044

Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period

Completed Last updated 7 January 2021
What this trial tests

trial testing Hospital Anxiety Depression Scale in Anxiety in 1,107 participants. Completed in 25 June 2020.

Timeline
8 May 2020
Primary endpoint
25 June 2020
25 June 2020

Quick facts

Lead sponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,107
Start date8 May 2020
Primary completion25 June 2020
Estimated completion25 June 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Who can join

18 and older, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 pandemic has negatively affected individuals not only physiologically but also psychologically. The aim of this study is to examine the anxiety and depression status of cancer patients, individuals with non-cancer chronic diseases and healthy individuals with an online screening questionnaire during the COVID-19 pandemic period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04698044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing